Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab

The current pandemic emergence of novel coronavirus disease (COVID-19) poses a relevant threat to global health. SARS-CoV-2 infection is characterized by a wide range of clinical manifestations, ranging from absence of symptoms to severe forms that need intensive care treatment. Here, plasma-EDTA sa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PLoS pathogens 2021-02, Vol.17 (2), p.e1009243-e1009243, Article 1009243
Hauptverfasser:	Meoni, Gaia, Ghini, Veronica, Maggi, Laura, Vignoli, Alessia, Mazzoni, Alessio, Salvati, Lorenzo, Capone, Manuela, Vanni, Anna, Tenori, Leonardo, Fontanari, Paolo, Lavorini, Federico, Peris, Adriano, Bartoloni, Alessandro, Liotta, Francesco, Cosmi, Lorenzo, Luchinat, Claudio, Annunziato, Francesco, Turano, Paola
Format:	Artikel
Sprache:	eng
Schlagworte:	Accuracy Antibodies, Monoclonal, Humanized - administration & dosage Biology and Life Sciences Blood cells Carboxylates Cardiovascular disease Cholesterol Citric acid Coronary artery Coronary artery disease Coronaviruses COVID-19 COVID-19 - blood COVID-19 - drug therapy COVID-19 - epidemiology Cytokines Erythrocytes Ethylenediaminetetraacetic acids Female Heart diseases High density lipoprotein Humans Hypoxia Immunosuppressive agents Infections Intensive care Life Sciences & Biomedicine Lipidomics Lipids Lipids - blood Low density lipoprotein Male Medicine and Health Sciences Metabolites Metabolomics Microbiology Monoclonal antibodies Neutrophils NMR NMR spectroscopy Nuclear magnetic resonance Nuclear Magnetic Resonance, Biomolecular Pandemics Parasitology Patients Phenylalanine Plasma Pneumonia Principal components analysis Research and analysis methods SARS-CoV-2 - metabolism Science & Technology Sepsis Severe acute respiratory syndrome coronavirus 2 Spectroscopy Spectrum analysis Tyrosine Ventilators Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!